The UK government will classify etomidate and related compounds as controlled substances under the Misuse of Drugs Act 1971. The Advisory Council on the Misuse of Drugs (ACMD) conducted a comprehensive safety review that prompted this etomidate control UK decision.

Minister for Policing and Crime Sarah Jones MP wrote to Professor David Wood, Chair of the ACMD, and Professor Simon Thomas, Chair of the ACMD New Psychoactive Substances Committee, on 19 January 2026. Her letter outlined the government’s response to growing concerns about the dangerous sedative and its emerging presence in vaping products.

Etomidate Control UK: Class C Classification

The new etomidate regulation framework in Britain will list the substance as a Class C drug. This places it alongside other sedatives such as benzodiazepines, zopiclone, and pregabalin. Parliament will implement the changes when time allows. The government plans to consult stakeholders before starting the legislative process.

Medical practitioners currently use etomidate under licence. Authorities will list it in Schedule 4 (Part 1) of the Misuse of Drugs Regulations 2001. Related compounds have no legitimate medical use. These will go into Schedule 1.

Minister Jones noted that etomidate use in the UK appears limited. However, she warned that “its usage is likely to be underestimated due to a lack of routine testing.” The ACMD’s Novel Psychoactive Substances Committee found something troubling. Reports from Asia and New Zealand show etomidate appearing widely in e-liquids. This means the true availability is probably far higher than current UK data suggests.

Enhanced Testing for Etomidate Regulation in Britain

The government accepted recommendations to strengthen testing of seized vaping products. Border Force, police forces, and the National Crime Agency will submit contaminated vapes for analysis. All agencies acknowledged that funding constraints pose a challenge.

The National Police Chiefs’ Council supports enhanced testing objectives. They note that trading standards, education, and health partners handle vape education and awareness. Police services across all UK nations made similar commitments.

The Office for Health Improvement and Disparities (OHID) will monitor detection levels closely. They track multiple data sources. These include forensic testing of seized drugs and biological samples. Vape liquid samples will receive special attention under the new etomidate control UK measures.

International Collaboration Strengthened

International cooperation will support Britain’s etomidate regulation efforts. The government confirmed that the UK and the European Union Drugs Agency (EUDA) are developing working arrangements. A UK-EU Summit in May 2025 agreed to this cooperation.

OHID exchanges data through the United Nations Office on Drugs and Crime’s Early Warning Advisory system. This system collects information on novel psychoactive substances worldwide. The UK will strengthen this engagement as national surveillance capabilities expand. Officials also follow the United States National Drug Early Warning System through weekly reports and regular webinars.

Public Health Information Campaign

All four UK nations will develop information resources about etomidate and its health risks. OHID is creating dedicated content for the government’s Talk to Frank website in England. The content will specifically address etomidate’s potential presence in vaping products.

Wales will work with its DAN 24/7 helpline. Scotland’s Know The Score website will provide appropriate information. Northern Ireland’s Public Health Agency will ensure all key stakeholders receive necessary guidance. Officials from all four governments will coordinate their activities to avoid duplication.

The National Poisons Information Service is producing a TOXBASE page on etomidate exposures. This will support healthcare professionals who manage cases.

Minister Jones stressed the importance of public awareness given the wide usage of vaping products. She expressed concerns about inadvertent overdose risks. The sedative effects could make individuals vulnerable to harm and acquisitive crime.

The etomidate control in the UK and the etomidate regulation in Britain represent a proactive approach to an emerging threat. Comprehensive monitoring and public education form key pillars of the government’s strategy. The aim is clear: protect public health and keep streets safe.

Source: dbrecoveryresources